Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - REGENERX BIOPHARMACEUTICALS INC | w78085sv1.htm |
| EX-4.2 - EX-4.2 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w2.htm |
| EX-3.2 - EX-3.2 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w2.htm |
| EX-3.4 - EX-3.4 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w4.htm |
| EX-4.4 - EX-4.4 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w4.htm |
| EX-3.1 - EX-3.1 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w1.htm |
| EX-4.3 - EX-4.3 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w3.htm |
| EX-4.1 - EX-4.1 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w1.htm |
| EX-23.1 - EX-23.1 - REGENERX BIOPHARMACEUTICALS INC | w78085exv23w1.htm |
Exhibit 3.3
CERTIFICATE OF AMENDMENT
OF
RESTATED CERTIFICATE OF INCORPORATION
Alpha 1 Biomedicals, Inc., a corporation organized and existing under and by virtue of
the General Corporation Law of the State of Delaware,
DOES HEREBY CERTIFY:
FIRST: That at a meeting of the Board of Directors of Alpha 1 Biomedicals, Inc.,
resolutions were adopted setting forth proposed amendments to the Restated Certificate of
Incorporation of said corporation, declaring said amendments to be advisable and directing
that such amendments be considered at the next Annual Meeting of Stockholders of said
corporation. The resolutions setting forth the proposed amendments are as follows:
RESOLVED, that Section 1 of the Restated Certificate of Incorporation of the Company be
amended to read as follows:
“1. Name. The name of the corporation is RegeneRx Biopharmaceuticals, Inc.”
FURTHER RESOLVED, that Section 4 of the Restated Certificate of Incorporation of the
Company be amended to read as follows:
“4. Authorized Capital Stock. The total number of shares of capital stock which
the Corporation shall have the authority to issue is One Hundred One Million (101,000,000)
shares divided into two classes of which One Million (1,000,000) shares of the par value of
$.001 per share shall be designated Preferred Stock and One Hundred Million (100,000,000)
shares of the par value of $.001 per share shall be designated Common Stock.”
SECOND: That thereafter, at the Annual Meeting of Stockholders of said corporation held
on December 15, 2000, pursuant to notice in accordance with Section 222 of the General
Corporation Law of the State of Delaware, the necessary number of shares as required by
statute were voted in favor of the amendments.
THIRD: That said amendments were duly adopted in accordance with the applicable
provisions of Section 242 of the General Corporation Law of the State of Delaware.
IN WITNESS WHEREOF, said corporation has caused this certificate to be signed by Allan L.
Goldstein, its President and Chief Executive Officer, this 15th day of December, 2000.
| ALPHA 1 BIOMEDICALS, INC. | ||||||
| BY: | /s/ Allan L. Goldstein | |||||
| Allan L. Goldstein | ||||||
| President and Chief Executive Officer | ||||||
2